Pierrepont Therapeutics Email Formats
Biotechnology Research • 
United States • 1-10 Employees
Pierrepont Therapeutics Email Formats
Pierrepont Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@pierreponttx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@pierreponttx.com | 100% |
Key Contact at Pierrepont Therapeutics
Matthew G. Wyckoff
Co-Founder
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
About Pierrepont Therapeutics
Pierrepont Therapeutics, Inc. is dedicated to developing targeted treatments for primary mitochondrial and other rare genetic diseases. Pierrepont's lead product candidate, PTI-501 (formerly ENTR-501) is a proprietary intracellular enzyme replacement therapy for the treatment of MNGIE that is exclusively licensed from Entrada Therapeutics, Inc. (Nasdaq: TRDA). The founders of Pierrepont have unique expertise and success in mitochondrial disease drug development, and have strong relationships with KOLS, families, and patient advocacy groups in the mitochondrial disease community. For more information, please contact info@PierrepontTx.com.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Pierrepont Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Pierrepont Therapeutics has never raised funding before.
Pierrepont Therapeutics Tech Stack
Discover the technologies and tools that power Pierrepont Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
JavaScript libraries
Miscellaneous
Security
SSL/TLS certificate authorities
Web servers
United Arab Emirates
Germany
France
Canada
United Kingdom
South AfricaFrequently asked questions
4.8
40,000 users
